Related Experiment Video

Updated: Nov 16, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

30.6K

Characterization of the novel HLA-B*35:29:03 allele by next-generation sequencing

Grégory Gatouillat1, Thierry Tabary1, Vincent Elsermans2

  • 1CHU de Reims, Laboratoire d'immunologie, Pôle de Biologie Médicale et Pathologie, Reims, France.

HLA
|February 24, 2021
PubMed

Abstract:

HLA-B*35:29:03 differs from HLA-B*35:29:01 by one nucleotide substitution at position 374 in exon 2.

Keywords:
HLAHLA-B*35:29:03next-generation sequencingnovel allele

More Related Videos

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.4K
High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

12.1K

Related Experiment Videos

Last Updated: Nov 16, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

30.6K
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.4K
High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

12.1K

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

95.8K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
95.8K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

14.9K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.9K

Articles linked to this work by shared authors, journal, and citation graph.

Characterisation of the Novel HLA-A*32:200 Allele by Sequencing-Based Typing.

HLA·2026

Characterisation of the Novel HLA-B*15:753 Allele by Sequencing-Based Typing.

HLA·2026

Characterisation of the Novel HLA-C*15:05:21 Allele by Sequencing-Based Typing.

HLA·2026

Characterisation of the Novel HLA-B*07:05:15 Allele by Sequencing-Based Typing.

HLA·2026

Characterisation of the Novel HLA-DQB1*03:618 Allele by Sequencing-Based Typing.

HLA·2026

Characterisation of the Novel HLA-A*02:1295N Allele by Sequencing-Based Typing.

HLA·2026

Identification of the Null Allele HLA-A*23:157N Characterised by a Two Nucleotide Insertion in Exon 3.

HLA·2026

Detection of the Novel HLA-A*01:522 Allele by Next-Generation Sequencing in a Brazilian Individual.

HLA·2026

Characterisation of the Novel HLA-C*08:334 Allele in a Brazilian Volunteer Donor.

HLA·2026

Characterisation of the Novel HLA-C*17:03:08 Allele Identified in a Brazilian Bone Marrow Donor.

HLA·2026

Characterisation of HLA-C*12:118:02 in a Brazilian Volunteer Bone Marrow Donor.

HLA·2026

Characterisation of the Novel HLA-C*16:245 Allele by Next-Generation Sequencing.

HLA·2026

Identification of the Novel HLA-DQB1*05:385 Allele Through Next-Generation Sequencing.

HLA·2026

Uncommon Concurrent Retinal and Cerebral Metastasis in High-risk Neuroblastoma: Diagnostic Utility of 68Ga-DOTATATE PET/CT Despite Negative 18F-FDG PET/CT.

Clinical nuclear medicine·2026

Identification of the Novel HLA-A*68:346 Allele in a Brazilian Individual by Next-Generation Sequencing.

HLA·2026

Immunoglobulin Superfamily Protein BTNL9 Functions as a Non-Canonical Transcriptional Regulator to Suppress NSCLC Through Cell Cycle and p53 Pathways.

International journal of molecular sciences·2026

Identification of the Novel HLA-DRB1*04:01:26 Allele by Next-Generation Sequencing.

HLA·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us